Poster featuring TILT technology will be presented at the European Society of Cell and Gene Therapy Annual Congress in Florence, Italy in October 2016.
A fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events: